NANOFORM FINLAND OY
502082-7530ActiveNanoforming technology enhances drug performance across development stages.
Oversikt
- 1–4
- Ansatte
- Ukjent
- Omsetning
- 2019
- Grunnlagt
Nøkkelbeslutningstakere
David Rowe
Head of Manufacturing
Christian Jones
Chief Commercial Officer
Antonio Da Silva
Manager
Albert Hæggström
Manager
+1 flere kontakter i Funnelfeedr
Beskrivelse
Nanoform is a pioneering pharmaceutical technology company specializing in advanced particle engineering services. They utilize their proprietary Controlled Expansion of Supercritical Solutions (CESS ®) process to transform drug formulations. Their core offering, nanoforming, enables pharmaceutica...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- Utländsk juridisk person
- MVA-nummer
- SE502082753001
Beslutningstakere
5 kontakter i FunnelfeedrDavid Rowe
Head of Manufacturing
Christian Jones
Chief Commercial Officer
Antonio Da Silva
Manager
Albert Hæggström
Manager
Peter Hänninen
Manager
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrDisruptive Pharma Operations AB
Transforming oral drugs via proprietary bioavailability enhancement technology.
RegenCura AB
1 ansatteCommercializing sustainable antimicrobial surfaces and advanced pollutant removal technology.
Veltio Pharma AB
3 ansatteProprietary platform enhances poorly soluble drug bioavailability using cellulose.
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
DELSITECH OY
Developing silica-based drug delivery technology for long-acting injectables.
Utforsk mer
Spørsmål om NANOFORM FINLAND OY
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo